COVID-19 Dermatology registry
COVID-19 Dermatology registry aims at collect cases of COVID-19 cutaneous manifestations. The registry is open to medical professionals only, from any specialty.
Description
More detailed information about this field from each metasource.
COVID-19 Dermatology registry aims at collect cases of COVID-19 cutaneous manifestations. The registry is open to medical professionals only, from any specialty.
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Webpage:
https://www.aad.org/member/practice/coronavirus/registryWebpage
More detailed information about this field from each metasource.
https://www.aad.org/member/practice/coronavirus/registry
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries
PMID: 32622888
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries
PMID: 32479979
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19
PMID: 32305438
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
International collaboration and rapid harmonization across dermatologic COVID-19 registries
PMID: 32562840
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Publications
More detailed information about this field from each metasource.
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries
PMID: 32622888
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries
PMID: 32479979
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19
PMID: 32305438
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
International collaboration and rapid harmonization across dermatologic COVID-19 registries
PMID: 32562840
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
-
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries
PubMed citations: 140.
140 articles citing: The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review. PMID:35892480
COVID toes following vaccination. PMID:35754589
Tissue immunity to SARS-CoV-2: Role in protection and immunopathology. PMID:35752871
Vaccine Toes Are the New COVID Toes. PMID:35664444
Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. PMID:35562767
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. PMID:35489015
Coronavirus Disease 2019 (COVID-19) and Ecchymosis: A Case Report. PMID:35464524
[Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm]. PMID:35357514
Dermatologic Manifestation of Acro-Ischemia Associated With COVID-19. PMID:35355646
A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms. PMID:35352414
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. PMID:35328761
Wells syndrome as a presenting sign of COVID-19 in the setting of allergic rhinitis and iron deficiency anemia. PMID:35261918
[COVID-19 and skin manifestations: overview of current literature]. PMID:35254461
Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report. PMID:35251600
Mucocutaneous lesions associated with SARS-CoV-2 infection (Review). PMID:35251324
Cutaneous Manifestations of SARS-CoV-2 Infection. PMID:35247198
Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? PMID:35244561
Acro-ischemic lesions in COVID-19 patients: A case series. PMID:35238135
Lack of association between pandemic chilblains and SARS-CoV-2 infection. PMID:35217624
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report. PMID:35186108
Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine. PMID:35169755
Therapeutics for COVID-19 and post COVID-19 complications: An update. PMID:35136858
Cutaneous Small-vessel Vasculitis after ChAdOx1 COVID-19 Vaccination: A Report of Five Cases. PMID:35130095
Pathological sequelae of long-haul COVID. PMID:35105985
A case report of COVID-19-associated erythema nodosum: a classic presentation with a new trigger. PMID:35078214
Skin manifestations in patients with coronavirus disease 2019. PMID:35067520
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. PMID:35045565
Paucity of cutaneous manifestations of COVID-19 among inpatients at a referral hospital in India. PMID:35036963
Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. PMID:34987516
Cutaneous Sarcoid-Like Reaction on Tattooed Skin after Recovery from Coronavirus Disease 2019. PMID:34980954
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. PMID:34945136
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. PMID:34920833
Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? PMID:34866636
Skin manifestations associated with COVID-19. PMID:34857407
COVID-19 and Its Repercussions on Oral Health: A Review. PMID:34833407
Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. PMID:34820228
Levamisole-induced and COVID-19-induced retiform purpura: two overlapping, emerging clinical syndromes. PMID:34807290
COVID-19-related skin manifestations: Update on therapy. PMID:34785023
Urticaire et angio-œdème associés à l’infection par le SRAS-CoV-2. PMID:34782386
Livedo Reticularis Associated with COVID-19. PMID:34776480
Dermatology on the global stage: The role of dermatologists in international health advocacy and COVID-19 research. PMID:34722850
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. PMID:34696346
Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. PMID:34670262
An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers. PMID:34667754
COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study. PMID:34667693
COVID-19 Skin Manifestations in Skin of Colour. PMID:34663122
Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence. PMID:34606671
Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19. PMID:34592006
[Cutaneous Manifestation of COVID-19: What Have we Learned an Year Into the Pandemic?]. PMID:34580541
COVID-19 and Dermatology: One Year in Review. PMID:34556255
How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries. PMID:34556253
Dermatology COVID-19 Registries: Updates and Future Directions. PMID:34556247
Coronavirus Disease 2019 and Race in Dermatology. PMID:34556246
Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. PMID:34556243
Cutaneous Manifestations of COVID-19 in the Inpatient Setting. PMID:34556242
Clinical Patterns and Morphology of COVID-19 Dermatology. PMID:34556240
Reactive infectious mucocutaneous eruption in children diagnosed with COVID-19. PMID:34542915
COVID-19-The American Perspective. PMID:34518000
Clinicopathologic features between different viral epidemic outbreaks involving the skin. PMID:34517998
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. PMID:34517079
Cutaneous Manifestations of COVID-19: An Experience From Oman. PMID:34513344
Urticaria and angioedema associated with SARS-CoV-2 infection. PMID:34493567
Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19. PMID:34462725
Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations. PMID:34458884
Papular purpuric gloves and socks syndrome in a patient with previous SARS-CoV-2 infection. PMID:34458534
The COVID rash that puts the 'U' in GROUCH! PMID:34456487
Dermatological Manifestations Associated with COVID-19 Infection. PMID:34446946
From asymptomatic to critical illness: decoding various clinical stages of COVID-19. PMID:34445855
Cutaneous maculopapular and vesicular lesions as the only presentation of COVID-19. PMID:34432295
Patient characteristics in tardive COVID-19 pseudoperniosis: a case series of 16 patients. PMID:34411313
Kidney involvement and histological findings in two pediatric COVID-19 patients. PMID:34406477
Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes. PMID:34385830
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. PMID:34363637
Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India. PMID:34297886
SARS-CoV-2 and guttate psoriasis: A case report and review of literature. PMID:34295501
Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries. PMID:34289146
A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. PMID:34272741
Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children. PMID:34272031
Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. PMID:34241899
A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. PMID:34235511
Cutaneous Manifestations in SARS-CoV-2 Infection-A Series of Cases from the Largest Infectious Diseases Hospital in Western Romania. PMID:34202233
Skin lesions in children during the first wave of the SARS-CoV-2 pandemic. PMID:34151022
The significance of exanthems in COVID-19 patients hospitalized at a tertiary care centre. PMID:34146347
The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19? PMID:34054828
Skin lesions in children during the first wave of the SARS-CoV-2 pandemic. PMID:34016448
Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection. PMID:34013600
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. PMID:33992686
Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. PMID:33978234
Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. PMID:33972045
International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries. PMID:33963765
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. PMID:33957949
Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. PMID:33931901
Skin Manifestation of SARS-CoV-2: The Italian Experience. PMID:33917774
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology. PMID:33914975
Systemic and organ-specific immune-related manifestations of COVID-19. PMID:33903743
New-onset chilblains in close temporal association to mRNA-1273 vaccination. PMID:33898675
Pernio after COVID-19 vaccination. PMID:33893637
Penile ischaemia secondary to COVID-19: why should the dermatologist be concerned? PMID:33866610
COVID-19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID-19 registry. PMID:33855708
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. PMID:33838206
Dermatology and COVID-19: Much knowledge to date but still a lot to discover. PMID:33781568
May 2021: Heterogeneity in reported skin manifestations of COVID-19 and vaccines. PMID:33775460
Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children. PMID:33772567
Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study. PMID:33771589
[The position of children in the pandemic and the role of COVID-19 in their lives]. PMID:33771462
Post-acute COVID-19 syndrome. PMID:33753937
Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity. PMID:33730393
Periocular capillaritis in a COVID-19-positive patient: report of a case. PMID:33724581
Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. PMID:33714595
Varicella complicated with pneumonia in a patient infected by COVID-19: the need to rule out other viral coinfections in SARS-CoV-2 patients with vesicular eruptions. PMID:33686647
Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review. PMID:33665200
Comment on "The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries". PMID:33640510
COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. PMID:33586189
Purpuric ulcers associated with COVID-19: A case series. PMID:33558846
Maculopapular skin eruptions associated with Covid-19: A systematic review. PMID:33481314
Skin manifestations of COVID-19: A worldwide review. PMID:33479703
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. PMID:33476725
Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. PMID:33460566
Exuberant bullous vasculitis associated with SARS-CoV-2 infection. PMID:33457205
Don't forget about syphilis: sexually transmitted diseases during COVID-19 pandemic. PMID:33437752
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. PMID:33401171
Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19. PMID:33359476
The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey. PMID:33301190
Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. PMID:33291502
Diffuse skin rash in tropical areas: Dengue fever or COVID-19? PMID:33281008
Palmar Erythema as the Sole Manifestation of COVID-19. PMID:33274164
Quoi de neuf en Dermatologie Pédiatrique: What’s new in pediatric dermatology? PMID:33267941
Pityriasis rosea as a leading manifestation of COVID-19 infection. PMID:33258224
Is there an under-representation of skin of colour images during the COVID-19 outbreak? PMID:33254574
The oral cavity cannot be forgotten in the COVID-19 era: Is there a connection between dermatologic and oral manifestations? PMID:33249067
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. PMID:33232965
COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report. PMID:33197843
Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases. PMID:33195784
An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report. PMID:33168054
COVID toes: where do we stand with the current evidence? PMID:33075530
Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers. PMID:33047260
A 47-Year-Old Hispanic Man Who Developed Cutaneous Vasculitic Lesions and Gangrene of the Toes Following Admission to Hospital with COVID-19 Pneumonia. PMID:32999267
Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City. PMID:32966592
Timing of PCR and antibody testing in patients with COVID-19-associated dermatologic manifestations. PMID:32920037
Paucity of COVID-19 dermatology literature from low- and middle-income countries. PMID:32866992 -
Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries
PubMed citations: 89.
89 articles citing: Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries
Urticarial rash as the initial presentation of COVID-19 infection: A case report. PMID:35846919
Vaccine Toes Are the New COVID Toes. PMID:35664444
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. PMID:35412072
Pandemic chilblains: Are they SARS-CoV-2-related or not? PMID:35338000
'Home-school toes' - a case series of paediatric perniosis presentations. PMID:35316542
Dermatological Manifestations of COVID-19 in Children. PMID:35273132
Cutaneous Manifestations of SARS-CoV-2 Infection. PMID:35247198
Lack of association between pandemic chilblains and SARS-CoV-2 infection. PMID:35217624
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report. PMID:35186108
Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. PMID:35129855
SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator. PMID:35002019
Skin manifestations associated with COVID-19. PMID:34857407
Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. PMID:34820228
Using secondary cases to characterize the severity of an emerging or re-emerging infection. PMID:34737277
Teledermatology in the time of COVID-19. PMID:34714575
Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. PMID:34670262
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. PMID:34667308
COVID-19 Skin Manifestations in Skin of Colour. PMID:34663122
Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study. PMID:34619397
Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as Mechanism. PMID:34570195
From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. PMID:34561087
COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide. PMID:34556254
Dermatology COVID-19 Registries: Updates and Future Directions. PMID:34556247
COVID-19 Pediatric Dermatology. PMID:34556241
Clinical Patterns and Morphology of COVID-19 Dermatology. PMID:34556240
No antibody response in cutaneous manifestations associated with COVID-19: An observational study of 64 cases with microbiological and clinical characterization. PMID:34549491
Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis. PMID:34545625
Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic? PMID:34530491
COVID toes: Pernio-like lesions. PMID:34517996
Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19. PMID:34462725
Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations. PMID:34458884
Cutaneous maculopapular and vesicular lesions as the only presentation of COVID-19. PMID:34432295
Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes. PMID:34385830
A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. PMID:34272741
Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. PMID:34241899
Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine. PMID:34236735
A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. PMID:34235511
Atypical erythema nodosum triggered by COVID-19 infection. PMID:34222573
Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. PMID:34110396
Skin disorders associated with the COVID-19 pandemic: A review. PMID:34077629
Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. PMID:33978234
Pediatric COVID toes and fingers. PMID:33972057
COVID-19: The experience from Italy. PMID:33972039
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. PMID:33957949
Systemic and organ-specific immune-related manifestations of COVID-19. PMID:33903743
[Post-COVID syndrome: A reflection and opinion paper]. PMID:33878844
Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? PMID:33866618
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. PMID:33838206
Mucocutaneous manifestations in children hospitalized with COVID-19. PMID:33819537
"Face mask dermatitis" due to compulsory facial masks during the SARS-CoV-2 pandemic: data from 550 health care and non-health care workers in Germany. PMID:33814358
Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. PMID:33786450
Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA). PMID:33742457
Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. PMID:33714595
Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review. PMID:33665200
Cold and COVID: recurrent pernio during the COVID-19 pandemic. PMID:33657646
Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review. PMID:33653127
A convolutional neural network architecture for the recognition of cutaneous manifestations of COVID-19. PMID:33604961
Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses. PMID:33595840
Pseudo-chilblain lesions and COVID-19: a controversial relationship. PMID:33565096
Skin manifestations of COVID-19: A worldwide review. PMID:33479703
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. PMID:33476725
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. PMID:33401171
Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19. PMID:33359476
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children. PMID:33323343
Chilblain-like eruption in COVID-19 disease: possible pathogenetic role of temperature. PMID:33319768
Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. PMID:33291502
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection. PMID:33278049
Quoi de neuf en Dermatologie Pédiatrique: What’s new in pediatric dermatology? PMID:33267941
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. PMID:33232965
Cutaneous manifestations of coronavirus disease 2019 in 458 confirmed cases: A systematic review. PMID:33209764
Skin manifestations of COVID-19 in children: Part 1. PMID:33180982
COVID toes: where do we stand with the current evidence? PMID:33075530
Cutaneous Manifestations of COVID-19: A Systematic Review. PMID:33035150
Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google Trends. PMID:33010073
Purpuric rash on the legs of a patient with coronavirus disease. PMID:32965453
A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19). PMID:32849867
Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature. PMID:32844512
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic. PMID:32822790
Acro-ischemic lesions associated with extremely elevated D-Dimer in a child during the COVID-19 pandemic. PMID:32808275
A visually striking case of primary acrocyanosis: A rare cause of the blue digit. PMID:32800682
Changing trends in dermatology practice during COVID-19 pandemic: A single tertiary center experience. PMID:32767466
Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. PMID:32745281
COVID toes: Phenomenon or epiphenomenon? PMID:32682878
SARS-CoV-2-related chilblains. PMID:32660940
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. PMID:32628270
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. PMID:32622888
Acral purpuric lesions associated with coagulation disorders during the COVID-19 pandemic. PMID:32614069
The mystery of the COVID toes - turning evidence-based medicine on its head. PMID:32576291
When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection. PMID:32565206 -
The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19
PubMed citations: 31.
31 articles citing: The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review. PMID:35892480
Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. PMID:34820228
Dermatology on the global stage: The role of dermatologists in international health advocacy and COVID-19 research. PMID:34722850
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. PMID:34696346
Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. PMID:34670262
COVID-19 Skin Manifestations in Skin of Colour. PMID:34663122
COVID-19 and Dermatology: One Year in Review. PMID:34556255
How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries. PMID:34556253
Dermatology COVID-19 Registries: Updates and Future Directions. PMID:34556247
Clinical Patterns and Morphology of COVID-19 Dermatology. PMID:34556240
Impact of COVID-19 on autoimmune blistering diseases. PMID:34517993
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. PMID:34517079
Data Empowerment of Decision-Makers in an Era of a Pandemic: Intersection of "Classic" and Artificial Intelligence in the Service of Medicine. PMID:34313589
A convolutional neural network architecture for the recognition of cutaneous manifestations of COVID-19. PMID:33604961
Skin manifestations in COVID-19 patients, state of the art. A systematic review. PMID:33533036
Spatial statistical analysis of pre-existing mortalities of 20 diseases with COVID-19 mortalities in the continental United States. PMID:33532175
Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019. PMID:33521582
Regional COVID-19 registry in Khuzestan, Iran: A study protocol and lessons learned from a pilot implementation. PMID:33495736
Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. PMID:33460566
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. PMID:33291346
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. PMID:33075408
Vesicular (varicella-like) eruptions. PMID:33008676
Covid-19 pandemic and the skin. PMID:32954488
Timing of PCR and antibody testing in patients with COVID-19-associated dermatologic manifestations. PMID:32920037
The Multifaceted Engagement of the Dermatologist in the Covid-19 Pandemic. PMID:32838174
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. PMID:32622888
Chilblain and Acral Purpuric Lesions in COVID-19. PMID:32565054
International collaboration and rapid harmonization across dermatologic COVID-19 registries. PMID:32562840
Cutaneous manifestations of COVID-19: A preliminary review. PMID:32422225
Cutaneous signs in COVID-19 patients: A review. PMID:32390279
Big data and cutaneous manifestations of COVID-19. PMID:32305440 -
International collaboration and rapid harmonization across dermatologic COVID-19 registries
PubMed citations: 9.
9 articles citing: International collaboration and rapid harmonization across dermatologic COVID-19 registries
COVID-19 and Dermatology: One Year in Review. PMID:34556255
Dermatology COVID-19 Registries: Updates and Future Directions. PMID:34556247
Clinical Patterns and Morphology of COVID-19 Dermatology. PMID:34556240
Learning from disease registries during a pandemic: Moving toward an international federation of patient registries. PMID:34518006
Global infectious disease research collaborations in crises: building capacity and inclusivity through cooperation. PMID:34311748
Response to: "Comment on 'The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries'". PMID:33640507
Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. PMID:33485957
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis. PMID:33122022
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. PMID:33075408
Tags:
Tags
More detailed information about this field from each metasource.
patient care
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Tags
More detailed information about this field from each metasource.
patient care
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-19 Dermatology registry; COVID-19 Dermatology registry; DOI: https://doi.org/10.25504/FAIRsharing.Qyq85j; Last edited: May 20, 2021, 1:43 p.m.; Last accessed: Jan 03 2022 7:06 p.m.
Need help integrating and/or managing biomedical data?